Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiation and High-Dose Dexamethasone for Elderly PCNSL
NCT00003278Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 1998
- Primary completion
- Jun 2003
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of dexamethasone in primary central nervous system lymphoma (PCNSL), sponsored by Cancer and Leukemia Group B. Primary endpoint: Overall Survival at 5 years. Started Mar 1998; status: completed.
02
Drugs
dexamethasone
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00003278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003278.